QBiotics Capital Raise To Fund Development Of Blushwood Cancer Compounds

New Stories

• BMS therapy secures Australian approval for psoriatic arthritis

  September 3, 2026 -

• The live lesson from the UK on who holds the levers and how they use them

  September 3, 2026 -

• Gilead returns to Medicines Australia as industry prepares to make the case for innovation

  September 3, 2026 - - Latest News

• Combined monitoring of key indicators as the future of diabetes care

  September 3, 2026 -

• ENA Respiratory secures funding to test antiviral nasal spray in people with asthma

  September 2, 2026 -

• OncoSil pursues a reimbursement pathway as it prepares for US rollout

  September 2, 2026 - - Australian Biotech

• Vitrafy takes its cryopreservation technology into the US cell therapy market

  September 2, 2026 - - Australian Biotech